For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
National Review
The Return of the Cadillac Tax?
Like the phoenix, a key piece of the Affordable Care Act has risen from the ashes, resurrected, believe it or not, by the Republican Study Committee…
Blog
Free the Economy podcast: Paying for organs with Pete Jaworski
In this week’s episode we cover the future of AI and employment, why we shouldn’t trust Chinese economic statistics, and how the…
Search Posts
Op-Eds
Brussels’ Bad Science Will Cost the World Dear
Regulatory officials in the European Union seem to be ignorant of the rule of holes: when you are in one, stop digging. Numerous analyses…
Op-Eds
The Brundtland Legacy
The five-year tenure of Gro Harlem Brundtland as head of the World Health Organisation (WHO) has just come to an end. She leaves behind…
Op-Eds
Los Beneficios de la Biotecnologa
Click on pdf link above to obtain full article…
Op-Eds
The Benefits of Biotech
Click pdf link above for full text of article Ever since the publication of Rachel Carson’s…
USA Today
Republican Senator, Auto-Safety Advocate Form Unlikely Alliance
Op-Eds
Misfires in Biotech Trenches
Agricultural biotechnology suddenly is headline news—the focus of a vitriolic trans-Atlantic trade squabble, and even the subject of pointed public comments by President…